Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mustang Bio (MBIO) has provided an update.
Mustang Bio, Inc. has entered into an agreement with H.C. Wainwright & Co. to potentially sell shares of its common stock at market prices. The company can sell shares up to $5.6 million under this new arrangement, subject to SEC regulations. Additionally, Mustang Bio terminated its previous sales agreement, effective June 5, 2024, which had allowed for the sale of up to $100 million in common stock. This strategic shift in its stock offering approach allows for sales at times and amounts of the company’s choosing, with a 3% commission to the managing firm.
See more data about MBIO stock on TipRanks’ Stock Analysis page.